CSL execs to join Vifor board as takeover edges closer
MELBOURNE: CSL’s $16.4 billion takeover of Swiss pharma firm Vifor is inching closer, with the
MELBOURNE: CSL’s $16.4 billion takeover of Swiss pharma firm Vifor is inching closer, with the